Haemolysed sample identification in BA/BE study and others [Regulatives / Guidelines]

posted by vish14184 – India, 2018-05-09 19:43 (2235 d 19:43 ago) – Posting: # 18759
Views: 1,955

Dear all,

Please share your experience/view on below points. Thank you in advance.

1. Is it acceptable regulatory point of view (AnVIsa, EMA), If we identify haemolysed samples with it's grade (severe, moderate, slightly) during sample receipt in bioanalytical lab instead of haemolysed sample identification at clinical stage during sample separation as per defined procedure in SOP.

2. As per ANVISA requirements: is it required to evaluate ECG by cardiologist in BA/BE Study or ECG evaluation by medical qualified person is acceptable?

3. What is x-ray validity is acceptable for BA/BE Study? One year is acceptable if Ethics committee approving it.

Thank you

With regards

Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,649 registered users;
37 visitors (0 registered, 37 guests [including 8 identified bots]).
Forum time: 15:26 CEST (Europe/Vienna)

There are only two kinds of scholars;
those who love ideas and those who hate them.    Emile Chartier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz